Literature DB >> 14507667

Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Masako Ochiai1, Mitsunori Ushigome, Kyoko Fujiwara, Tsuneyuki Ubagai, Toshihiko Kawamori, Takashi Sugimura, Minako Nagao, Hitoshi Nakagama.   

Abstract

The multistage model of colon carcinogenesis is well established in both humans and experimental animals, and aberrant crypt foci (ACF) are generally assumed to be putative preneoplastic lesions of the colon. However, morphological analyses of ACF have suggested that they are highly heterogeneous in nature and their role in tumorigenesis is still controversial. To better understand the biological significance of ACF in carcinogenesis, morphological and genetic analyses were performed using a rat colon cancer model induced by a food-borne colon carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). ACF of different sizes were collected at weeks 6, 18, 25, and 32 after three cycles of 2-week PhIP feeding (400 ppm in diet) with 4-week intervals on a high-fat diet, and a total of 110 ACF, representing approximately three-quarters of the total ACF, were subjected to histological evaluation. Thirty (27%) were diagnosed as dysplastic ACF, based on cytological and structural abnormalities of crypts. Dysplastic ACF were detected even at week 6 (0.4 per rat), and the numbers increased slightly at later time points, being 0.8, 1.4, and 0.8 per rat at weeks 18, 25, and 32, respectively. The sizes of these dysplastic ACF varied widely from 1 to 16 crypts and 50% (15 of 30) were composed of less than 4 crypts. Immunohistochemical analysis revealed that 83% (25 of 30) of dysplastic ACF demonstrated beta-catenin accumulation; 22 only in the cytoplasm and 3 in both the cytoplasm and nucleus, the latter manifesting a higher grade of dysplasia as compared with the former. Seven dysplastic ACF harbored beta-catenin mutations at codon 32, 34, or 36 in exon 2, and one had an Apc mutation at the boundary of intron 10 and exon 11. Mutations at these sites were also commonly found in colon tumors induced by PhIP. The results of our present study indicate that dysplastic ACF, which accounted for approximately one-fourth of the total ACF, are preneoplastic lesions of colon cancers induced by PhIP in rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507667      PMCID: PMC1868301          DOI: 10.1016/S0002-9440(10)63517-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Chemoprevention of colorectal cancer.

Authors:  P A Jänne; R J Mayer
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

Review 2.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

3.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

Review 4.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

5.  Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.

Authors:  M Takahashi; M Mutoh; T Kawamori; T Sugimura; K Wakabayashi
Journal:  Carcinogenesis       Date:  2000-07       Impact factor: 4.944

6.  Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA).

Authors:  M Takahashi; M Fukutake; T Isoi; K Fukuda; H Sato; K Yazawa; T Sugimura; K Wakabayashi
Journal:  Carcinogenesis       Date:  1997-07       Impact factor: 4.944

7.  Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.

Authors:  Y Yamada; N Yoshimi; Y Hirose; K Kawabata; K Matsunaga; M Shimizu; A Hara; H Mori
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  Enhancement of experimental colon cancer by genistein.

Authors:  C V Rao; C X Wang; B Simi; R Lubet; G Kelloff; V Steele; B S Reddy
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

9.  Identification and quantification of aberrant crypt foci in the colon of Min mice--a murine model of familial adenomatous polyposis.

Authors:  J E Paulsen; E Namork; I L Steffensen; T J Eide; J Alexander
Journal:  Scand J Gastroenterol       Date:  2000-05       Impact factor: 2.423

10.  More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats.

Authors:  T Tsukamoto; H Tanaka; H Fukami; M Inoue; M Takahashi; K Wakabayashi; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  2000-08
View more
  11 in total

1.  Chemopreventive effects of non-steroidal anti-inflammatory drugs in early neoplasm of experimental colorectal cancer: an apoptosome study.

Authors:  Vivek Vaish; Lalita Tanwar; Jasmeet Kaur; Sankar Nath Sanyal
Journal:  J Gastrointest Cancer       Date:  2011-12

2.  Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving beta-catenin, c-Myc and E2F1.

Authors:  Q Li; W M Dashwood; X Zhong; H Nakagama; R H Dashwood
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

3.  Tumors from rats given 1,2-dimethylhydrazine plus chlorophyllin or indole-3-carbinol contain transcriptional changes in beta-catenin that are independent of beta-catenin mutation status.

Authors:  Rong Wang; W Mohaiza Dashwood; George S Bailey; David E Williams; Roderick H Dashwood
Journal:  Mutat Res       Date:  2006-07-24       Impact factor: 2.433

4.  The role of NF-κB and PPARγ in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors.

Authors:  Vivek Vaish; Lalita Tanwar; Sankar Nath Sanyal
Journal:  Tumour Biol       Date:  2010-06-01

Review 5.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

6.  Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation.

Authors:  Ravinder Tammali; Aramati B M Reddy; Kota V Ramana; J Mark Petrash; Satish K Srivastava
Journal:  Carcinogenesis       Date:  2008-11-20       Impact factor: 4.944

7.  Time course of the incidence/multiplicity and histopathological features of murine colonic dysplasia, adenoma and adenocarcinoma induced by benzo[a]pyrene and dextran sulfate sodium.

Authors:  Jiro Sonoda; Yuki Seki; Atsushi Hakura; Satoru Hosokawa
Journal:  J Toxicol Pathol       Date:  2015-03-01       Impact factor: 1.628

8.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

Review 9.  Colon preneoplastic lesions in animal models.

Authors:  Masumi Suzui; Takamitsu Morioka; Naoki Yoshimi
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

10.  Newly defined aberrant crypt foci as a marker for dysplasia in the rat colon.

Authors:  Masako Ochiai; Yoshitaka Hippo; Masashi Izumiya; Masatoshi Watanabe; Hitoshi Nakagama
Journal:  Cancer Sci       Date:  2014-07-12       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.